SAPPE revealed that international sales continue to grow, along with expanding its customer base both in Thailand and abroad, particularly in Asia, America, and Europe (excluding the Middle East). This supports full-year performance in line with the revenue growth target of 10-15% from the previous year's 5,372.91 million baht. In the first half of this year, revenue has already reached 2,850.74 million baht, and 10 new SKUs have been launched. Meanwhile, the appointment of a second distributor in Indonesia has been postponed to early 2027 due to delays in registration with the Food and Drug Administration, but the market is still seen as having high potential. The increase in shipping costs has not had a significant impact due to the use of FOB trade terms, and the company plans to open a new production line in 2027 to increase production capacity by another 25-30% from the current utilization of 60% at the Pathum Thani plant. It also continues to push Zero Sugar products to meet health trends.
Sappe Public Company LimitedInternational sales growth and expanding customer base support revenue target.
